A Personalized Surveillance and Intervention Protocol for Duodenal and Gastric Polyposis in Patients With Familial Adenomatous Polyposis
Recruiting now
Conditions studied: Familial Adenomatous Polyposis
In brief
The purpose of this study is to determine the efficacy and safety of a personalized surveillance and intervention protocol for duodenal and gastric polyposis in patients with familial adenomatous polyposis (FAP)
Key facts
- Study ID
- NCT04677998
- Run by
- Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
- People needed
- 1000
- Starts
- 2020-11-24
- Expected to finish
- 2027-11-01
- Last updated by the study team
- 2026-02-23
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Diagnosis of FAP, at least one of following: genetic diagnosis (proven APC germline mutation) and/or clinical diagnosis (>100 colorectal adenomas in combination with a positive family history of FAP)
- Age 18 years or older
You may not qualify if…
- Endoscopic removal of all polyps with an indication for removal not possible/feasible
- Gastric or duodenal cancer at baseline endoscopy
- Need for surgery
Where it is running
- MD Anderson — Houston, Texas, United States (enrolling)
- Academic Medical Centre — Amsterdam, North Holland, Netherlands (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.